
IndraLab
Statements
Lumacaftor activates KCNH2. 2 / 2
|
2
reach
"Having shown that Lumacaftor rescued the hERG trafficking defect in the induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) of two LQT2 patients, we tested whether the commercial association Lumacaftor + Ivacaftor (LUM + IVA) could shorten the QTc in the same two patients."